NFkB Inducing Kinase NIK (MAP3K14) Rabbit Polyclonal Antibody – TA336951 | OriGene
NF-κB pathway and the Goldilocks principle: Lessons from human disorders of immunity and inflammation - Journal of Allergy and Clinical Immunology
Metformin-induced suppression of Nemo-like kinase improves erythropoiesis in preclinical models of Diamond–Blackfan anemia through induction of miR-26a - Experimental Hematology
The discovery of quinoline derivatives, as NF-κB inducing kinase (NIK) inhibitors with anti-inflammatory effects in vitro, low toxicities against T cell growth - ScienceDirect
NIK promotes tissue destruction independently of the alternative NF-κB pathway through TNFR1/RIP1-induced apoptosis. - Abstract - Europe PMC
Cells | Free Full-Text | Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets
Recombinant human NFkB Inducing Kinase NIK protein (ab105210) | Abcam
NIK Antibody | 3193R | BioVision, Inc.
Recombinant Human NFkB Inducing Kinase NIK protein (ab61262) | Abcam
Detecting Kinase Activity Across the Kinome
NF-κB Signaling | NF-kappaB Pathway
Downregulation of TRAF2 Mediates NIK-Induced Pancreatic Cancer Cell Proliferation and Tumorigenicity
Frontiers | The NF-κB Signaling Pathway, the Microbiota, and Gastrointestinal Tumorigenesis: Recent Advances | Immunology
NIK SMI1 | ≥99%(HPLC) | Selleck | NF-κB inhibitor
Frontiers | Inhibition of NF-κB Signaling Pathway by Resveratrol Improves Spinal Cord Injury | Neuroscience
Cells | Free Full-Text | Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches | HTML
Frontiers | Regulation of Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κβ) in Inflammatory Bowel Diseases | Pediatrics
p53 Induces NF-κB Activation by an IκB Kinase-independent Mechanism Involving Phosphorylation of p65 by Ribosomal S6 Kinase 1* - Journal of Biological Chemistry
Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D0MD00361A
NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus | Nature Communications
Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D0MD00361A
p53 suppresses protein levels of NIK and non-canonical NF-κB activity.... | Download Scientific Diagram
The structure of Amgen NIK compounds. | Download Scientific Diagram
NIK compounds* inhibit NFkB activation mediated by Smac-mimetic in MM... | Download Scientific Diagram
Pharmacological inhibition of NF-κB-inducing kinase (NIK) with small molecules for the treatment of human diseases - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D0MD00361A
Inhibitors of NF-κB signaling: 785 and counting | Oncogene
